Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Glioblastoma 5Recurrence 4Head and Neck Neoplasms 3Diffuse Intrinsic Pontine Glioma 3Glioma 2Brain Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Recurrence of Head and Cancer in Irraiated Area 1Pelvic Neoplasms 1Pancreatic Neoplasms 1Nasopharyngeal Neoplasms 1Nasopharyngeal Diseases 1Nasopharyngeal Carcinoma 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Breast Cancer Recurrent 1Brain Stem Neoplasms 1

Interventions

Cisplatin 41Gemcitabine 25Fluorouracil 15Radiotherapy, Intensity-Modulated 14Radiotherapy 12Docetaxel 10pembrolizumab 8Paclitaxel 8Carboplatin 8Capecitabine 7Oxaliplatin 5toripalimab 4spartalizumab 4Bevacizumab 4camrelizumab 3Nivolumab 3Induction Chemotherapy 3Endostatins 3Cetuximab 3Acupuncture Therapy 3tislelizumab 2sintilimab 2nimotuzumab 2endostar protein 2apatinib 2Taxes 2Surveys and Questionnaires 2Polymerase Chain Reaction 2Nicotine 2Magnetic Resonance Spectroscopy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Nasopharyngeal Neoplasms × Re-Irradiation × Clear all
NCT03854838 2022-04-29

IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma.

Sun Yat-sen University

Phase 2 Unknown
25 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡